Skip to main content
. 2022 Apr 1;4(5):100460. doi: 10.1016/j.xkme.2022.100460

Table 4.

All-Cause Mortality and Cardiovascular Events Hazard Ratios from Individual Papers, Demonstrating Results from Their Most Fully Adjusted Model

Study Model All-Cause Mortality Cardiovascular Events Model Adjusted for
Weir et al10 Adjusted RR 1.4 (1.1-1.8) 1.3 (0.9-2.0) Matched patients from poorly dialyzable cohort to highly dialyzable cohort based on race, sex, and propensity scorea
Shireman et al6 Adjusted HR 0.84 (0.72-0.97) 0.86 (0.75-0.99) Cardioselectivity, start of β-blocker, age, sex, race, BMI category, smoker status, substance use status, employment, inability of ambulate. Inability to transfer, diabetes, congestive heart failure, cerebrovascular accident, peripheral vascular disease, hemoglobin, self-care dialysis
Assimon et al7 Adjusted HR 0.93 (0.86-0.98) 0.85 (0.78-0.93) Patient demographics, comorbid conditions, laboratory data, dialysis treatment parameters, and prescription medication use. Refer to Assimon et al7Table S2 for specifics
Wu et al8 Adjusted HR 0.82 (0.75-0.88) 0.89 (0.84-0.93) Age, sex, comorbid conditions, concomitant medications

Note: All-cause mortality and cardiovascular events hazard ratios and relative risks for highly dialyzable β-blockers versus poorly dialyzable β-blockers across the 4 studies. The average adjusted ratio was calculated using Review Manager.

Abbreviations: BMI, body mass index; HR, hazard ratio; IRR, incidence rate ratio; RR, risk ratio.

a

Weir et al10 matched their dialyzability cohorts based on the characteristics above instead of adjusting for the said characteristics.